Mark Conley - Interim Chief Financial Officer, Vice President of Finance at SAB Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Interim Chief Financial Officer, Vice President of Finance
Stock Symbol
SABS, SABSW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Conley since 7/15/2023

There are no transactions reported by Mark Conley for SAB Biotherapeutics, Inc.